Salivary gland neoplasms


This chapter discusses salivary gland tumors that occur with high frequency in the oral cavity with the understanding that even salivary gland tumors that tend to occur mostly in the major glands may also occur in the minor glands. Intraoral minor salivary gland neoplasms account for approximately 1% of non–hospital-based biopsy services, with 60% of these being benign.

The basic unit of minor and major salivary glands is the acinus and associated ductal system with the latter divided into intercalated, striated, and excretory ducts, with myoepithelial cells surrounding the acini and intercalated ducts ( Fig. 13.1 ). The acinotubular unit is composed of acini and ductal cells that together form the luminal cells, while the abluminal cells are composed of myoepithelial and basal cells that are not in direct contact with the lumen. Most tumors arise from the intercalated duct reserve cell or its precursor stem cell that differentiates into acinar, myoepithelial, and intercalated ductal cells and tumors that recapitulate these cells are SOX10 positive. The excretory duct reserve cell or its precursor stem cell differentiates into striated and excretory duct cells and gives rise to tumors such as mucoepidermoid carcinoma, salivary duct carcinoma, and oncocytic tumors and these are generally SOX10 negative. The immunohistochemistry of these cells in normal glands is presented in Fig. 13.1 .

FIG. 13.1
Structure and immunohistochemical studies of a normal salivary gland unit.

Traditionally salivary gland neoplasms have been diagnosed by histomorphology alone, although advances in immunohistochemistry, molecular diagnostics, and recognition of gene fusions have greatly advanced diagnosis of some tumors, reclassifying some tumors that have been diagnosed as “not otherwise specified” and reclassifying those that do not show classic histopathology but may be variants of well-recognized tumors ( Table 13.1 ).

TABLE 13.1
Gene Rearrangements and Other Genetic Abnormalities in Salivary Gland Tumors
Tumor Rearrangement or Mutation Prevalence
Sialadenoma papilliferum
  • BRAF V600E mutation

  • HRAS Q61R mutation

  • 70%– 1 00% of conventional type; 0% of oncocytic type

  • 1 2.5%

  • Pleomorphic adenoma

  • PLAG1

  • With fusion partners CTNNB1 , FGFR1 , LIFR , CHCHD7 , TCEA1 , NFIB , BOC and others

  • Oncocytic tumors exhibit fusion partners with GEM , CHCHD7 , NFT3 , FBXO32 , C1orf116

  • HMGA2

  • With fusion partners NFIB, WIF1, FHIT, TMTC2

  • HMGA2 amplifications have been reported

  • >50%

  • 1 0%– 1 5%

  • Less common

  • Salivary gland myoepithelioma

  • EWSR1 rearrangement

  • NTF3::PLAG1 fusion

  • FBXO32::PLAG1 fusion

  • GEM::PLAG1 fusion

  • 26.7%

  • Sclerosing polycystic adenoma

  • X-chromosome inactivation (polymorphisms in human androgen receptor [HUMARA])

  • PTEN, PIK3CA, PIK3RI mutations

  • 1 00%

  • 1 00%

  • 50%

  • Mucoepidermoid carcinoma

  • CRTC1::MAML2 fusion

  • CRTC3::MAML2 fusion

  • EWSR1::POU5F1 fusion

  • TP53, CDKN2A, PI3KCA, BAP, POU5F2 alterations

  • 50%–65% mostly in low grade tumors

  • 33%

  • Adenoid cystic carcinoma

  • MYB::NFIB fusion

  • MYBL1::NFIB fusion

  • Other fusion partners include PDCDILG2 , EFR3A , RAD51B , YTHDF3, and AIG1

  • NOTCH1, TERT, KDM6A, KMT2C mutations

  • 50%

  • 5%

  • 90%

  • Polymorphous carcinoma

  • Low-grade/conventional

  • Cribriform

  • PRKD1 E710D

  • PRKD1–3 rearrangements with various partners, e.g., ARID1A::PRKD1, DDX3X::PRKD1 fusions

  • 70%

  • 80%

  • Secretory carcinoma

  • ETV6::NTRK3 fusion

  • ETV6::RET fusion

  • ETV6::X fusion

  • VIM::RET , MYB::SMR3B, ETV6::MAML3, ETV6::MET, CTNNA::ALK fusions

  • 82%

  • 1 6%

  • Acinic cell carcinoma

  • NR4A3 rearrangement

  • HTN::MASNTD3 fusion

  • 84%

  • 4%–8%

  • Clear cell carcinoma

  • EWSR1::ATF1 fusion

  • EWSR::CREM fusion

  • 80%

  • Epithelial-myoepithelial carcinoma-adenoid cystic carcinoma

  • MYB rearrangement

  • 75%

  • Mucinous adenocarcinoma

  • (Including intraductal papillary mucinous neoplasm)

  • AKT1 W17K hot spot mutation

  • HRAS Q61R

  • RB1 mutation

  • MTOR mutation

  • BRCA2 , CDHI, PALB2 mutations

  • 1 00%

  • 44%

  • 38%

  • 25%

  • 1 3% each

  • 1 00%

  • Sclerosing microcystic adenocarcinoma

  • CDK11B

  • Microsecretory carcinoma

  • MEF2C::SS18 fusion

  • 1 00%

  • Salivary duct carcinoma

  • TP53 mutation

  • ERBB2 amplification

  • PTEN loss

  • HRAS mutation

  • PIK3CA mutation

  • BRAF mutation

  • 55%

  • 30%–35%

  • 38%

  • 23%–34%

  • 23%–33%

General principles

Benign and malignant intraoral salivary gland tumors occur in approximately equal proportions in the oral cavity. Reports from large medical centers may show a higher proportion of malignant tumors because of referral bias. In general, benign salivary gland neoplasms manifest similarly from a clinical perspective, regardless of the final histologic diagnosis. There is generally a female predominance with the exception of salivary duct carcinoma, which shows male predominance. Most occur in the fifth to seventh decades of life, and present as mobile, firm nodules; trauma may lead to ulceration. Unless otherwise specified, the palatal mucosa is the most common site for intraoral salivary gland tumors (50%–60% of cases), followed by the upper lip (15%–25% of cases) buccal mucosa and tongue. Notable exceptions to this rule are the canalicular adenoma which is most common in the upper lip, the cribriform variant of polymorphous adenocarcinoma which has a predilection for the tongue, and the microsecretory carcinoma with predilection for the lips.

References

  • Nagao T, Sato E, Inoue R, et al. Immunohistochemical analysis of salivary gland tumors: application for surgical pathology practice. Acta Histochem Cytochem . 2012;45:269-282.

  • Ohtomo R, Mori T, Shibata S, et al. SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis. Mod Pathol . 2013;26: 1041-1050.

  • Owosho AA, Aguilar CE, Seethala RR. Comparison of p63 and p40 (DeltaNp63) as basal, squamoid, and myoepithelial markers in salivary gland tumors. Appl Immunohistochem Mol Morphol . 2016;24:501-508.

  • Skalova A, Stenman G, Simpson RHW, et al. The role of molecular testing in the differential diagnosis of salivary gland carcinomas. Am J Surg Pathol . 2018;42:e11-e27.

  • Zhu S, Schuerch C, Hunt J. Review and updates of immunohistochemistry in selected salivary gland and head and neck tumors. Arch Pathol Lab Med . 2015;139:55-66.

Benign salivary gland neoplasms

Four entities exist within the group of benign intraductal papillary tumors namely intraductal papilloma, inverted papilloma, sialadenoma papilliferum, and papillary cystadenoma.

Intraductal papilloma

This is an uncommon condition and some reported as this entity may represent other conditions such as cystadenoma. It is essentially a papilloma arising from the duct lining that protrudes into the lumen.

Clinical findings

  • This occurs in the sixth decade and presents as a painless nodule or mass on the lips (most common site), and buccal and palatal mucosa ( Fig. 13.2 ).

    FIG. 13.2, (A) Intraductal papilloma of the left buccal mucosa. (B) Single, dilated excretory salivary duct with luminal papillary proliferation. (C) Well-organized papillary structures with fibrovascular cores and microcysts. (D) Surface luminal cells are cuboidal/columnar, and scattered mucous cells are present.

Etiopathogenesis and histopathologic features

Genomic changes have yet to be identified.

  • This lesion arises within a cystically dilated excretory salivary duct and consists of a benign papillary proliferation of cuboidal and columnar cells (especially on the luminal aspect), squamous cells, and mucous cells, with fibrovascular cores; microcysts are often present and the point of origin/attachment to the duct lumen may be evident ( Fig. 13.2 ).

  • Solid tumors that completely fill the lumen of the duct are likely to represent some other papillary neoplasm.

Differential diagnosis

  • Papillary cystadenoma consists of a proliferation of multiple cystic (infrequently unicystic) structures of varying size within which is ductal adenomatous hyperplasia composed of cuboidal-columnar or oncocytic cells forming papillary structures.

  • Mucinous adenocarcinoma, papillary type, has similar papillary structures composed of mucous cells but with solid and complex architecture. These exhibit AKT -E17K mutation.

  • Inverted ductal papilloma is endophytic and forms bulbous fronds of epithelium that invaginates into the connective tissue.

Management and prognosis

  • Excision is curative.

References

  • Aikawa T, Kishino M, Masuda T, et al. Intraductal papilloma arising from sublingual minor salivary gland: case report and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2009;107:e34-e37.

  • Brannon RB, Sciubba JJ, Giulani M. Ductal papillomas of salivary gland origin: a report of 19 cases and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2001;92:68-77.

  • Agaimy A. Papillary neoplasms of the salivary duct system: a review. Surg Pathol Clin . 2021;14:53-65.

Inverted ductal papilloma

Clinical findings

  • This occurs most frequently in the sixth and seventh decades and 60% occur in the lips and approximately 30% in the buccal mucosa as a painless nodule, sometimes with a punctum from which mucus may be expressed.

Etiopathogenesis and histopathologic features

This lesion is similar to a sinonasal inverted papilloma in histopathology but without malignant potential and there are too few cases to determine if these also exhibit EGFR mutation seen in 78% to 88% of sinonasal inverted papillomas.

  • There is an unencapsulated, discrete endophytic or “inverted”, lobular proliferation of squamous epithelium arising from an excretory salivary duct; clefts within the lobules represent extensions of the duct and the main duct often opens onto the surface. The lobules are composed of predominantly squamous cells, scattered mucous cells, and oncocytes, and ductal structures may be present lined by low cuboidal-to-columnar cells; microcysts are often seen ( Fig. 13.3 ).

    FIG. 13.3, Inverted ductal papilloma. (A) Bulbous endophytic growth arising from a duct. (B) Cuboidal-to-columnar cells seen on luminal surface with scattered mucous cells. (C) Cells have bland nuclear morphology, and there is microcyst formation.

  • Some cases show the presence of human papillomavirus (HPV)-6 and -11.

Differential diagnosis

  • Intraductal papillomas exhibit one large cystically dilated lumen with an intraluminal papillary epithelial proliferation, rather than the lobular endophytic proliferation of an inverted papilloma.

  • Papillary cystadenoma consists of a proliferation of multiple cystic structures each of which exhibits papillary and adenomatous hyperplasia.

  • Mucoepidermoid carcinoma may have a predominantly epidermoid component with only a few mucous and intermediate cells but is infiltrative and often forms small and large cysts. It exhibits CRTC1/3:: MAML2 fusion.

Management and prognosis

  • Excision is curative and the lesion does not tend to recur.

References

  • Brannon RB, Sciubba JJ, Giulani M. Ductal papillomas of salivary gland origin: a report of 19 cases and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2001;92:68-77.

  • Cabov T, Macan D, Manojlovic S, et al. Oral inverted ductal papilloma. Br J Oral Maxillofac Surg . 2004;42:75-77.

  • Do Canto AM, Mistro FZ, Kignel S, Martins F, Palmieri M, Braz-Silva PH. Oral inverted ductal papilloma: not related to HPV. Dermatol Online J . 2017;23:13030.

  • Haberland-Carrodeguas C, Fornatora ML, Reich RF, Freedman PD. Detection of human papillomavirus DNA in oral inverted ductal papillomas. J Clin Pathol . 2003;56:910-913.

  • Hegarty DJ, Hopper C, Speight PM. Inverted ductal papilloma of minor salivary glands. J Oral Pathol Med . 1994;23:334-336.

  • Jurgens PE. Inverted ductal papilloma of the lower lip: a case report. J Oral Maxillofac Surg . 2004;62:1158-1161.

  • Kubota N, Suzuki K, Kawai Y, et al. Inverted ductal papilloma of minor salivary gland: case report with immunohistochemical study and literature review. Pathol Int . 2006;56:457-461.

  • Udager AM, Rolland DCM, McHugh JB, et al. High-frequency targetable EGFR mutations in sinonasal squamous cell carcinomas arising from inverted sinonasal papilloma. Cancer Res . 2015;75: 2600-2606.

  • Wang H, Li H, Hu L, et al. EGFR and KRAS mutations in Chinese patients with sinonasal inverted papilloma and oncocytic papilloma. Histopathology . 2019;75:274-281.

Sialadenoma papilliferum

This is the salivary gland equivalent of the syringocystadenoma papilliferum of the skin.

Clinical findings

  • This occurs most frequently in the sixth and seventh decades with a 1.5:1 male predilection and the most common location is the hard palatal mucosa (60%–70% of cases) with the buccal mucosa affected in 10% of cases.

  • The lesion has a rough, warty appearance similar to a squamous papilloma.

Etiopathogenesis and histopathologic features

Seventy to 100% of conventional sialadenoma papilliferum show BRAF V600E mutation while the oncocytic type does not; 12.5% show HRAS mutation. BRAF mutations are also common in syringocystadenoma papilliferum, the skin counterpart.

  • Conventional type: There is a benign, nonencapsulated, exophytic papillary proliferation of surface squamous epithelium similar to a papilloma, in continuity with deep adenomatous and ductal hyperplasia that does not show stromal infiltration. There may be a subtle cribriform pattern and the ducts are irregularly shaped and branching, and are lined with bilayered cuboidal and myoepithelial cells, or with multiple cell layers, sometimes with papillary epithelial hyperplasia of ductal epithelium. Occasional mucous cells are present ( Fig. 13.4 ).

    FIG. 13.4, Sialadenoma papilliferum. (A) There is surface papillary squamous proliferation and adenomatous proliferation of ducts at base. (B) Adenomatous proliferation with papillary hyperplasia. (C) Luminal cells are cuboidal with spindled nuclei and there is a subtle cribriform architecture.

  • Oncocytic type: This is similar in all aspects to the conventional type except that the ductal epithelium is composed of oncocytic cells with abundant eosinophilic, granular cytoplasm, and round nuclei.

  • Luminal cells are K7+ and abluminal cells are p63+; BRAF is positive within both the glandular and squamous components.

  • Although cases have been reported showing dysplasia/carcinoma-in-situ and development of malignancy, these may represent de novo papillary carcinomas or cystadenocarcinomas.

Differential diagnosis

  • Squamous papilloma does not show the deep adenomatous hyperplasia but this may be the rendered diagnosis if the biopsy is small and superficial.

  • Papillary cystadenoma consists of multiple cystic (infrequently unicystic) structures within which protrude simple papillary structures lined by bland cuboidal bilayered epithelium bordered by a continuous layer of p63 positive abluminal cells; there is no surface exophytic papillary component.

  • Intraductal papillary mucinous neoplasm, noninvasive type, contains nucous cells and exhibits AKT1 mutation

Management

  • Excision is the treatment of choice and there is an up to 7% recurrence rate.

References

  • Brannon RB, Sciubba JJ, Giulani M. Ductal papillomas of salivary gland origin: a report of 19 cases and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2001;92:68-77.

  • Chen S, Peng J, Yuan C, Sun L, Zhang R, Sun Y. Sialadenoma papilliferum: clinicopathologic, immunohistochemical, molecular analyses of new five cases and review of the literature. Diagn Pathol . 2021;16:22.

  • Fowler CB, Damm DD. Sialadenoma papilliferum: analysis of seven new cases and review of the literature. Head Neck Pathol . 2018;12:193-201.

  • Hsieh MS, Bishop JA, Wang YP, et al. Salivary sialadenoma papilliferum consists of two morphologically, immunophenotypically, and genetically distinct subtypes. Head Neck Pathol . 2020;14:489-496.

  • Nakaguro M, Urano M, Ogawa I, et al. Histopathological evaluation of minor salivary gland papillary-cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm. Histopathology . 2020;76:411-422.

  • Ide F, Kikuchi K, Kusama K, Kanazawa H. Sialadenoma papilliferum with potentially malignant features. J Clin Pathol . 2010;63:362-364.

  • Liu W, Gnepp DR, de Vries E, et al. Mucoepidermoid carcinoma arising in a background of sialadenoma papilliferum: a case report. Head Neck Pathol . 2009;3:59-62.

Pleomorphic adenoma

The pleomorphic adenoma is the most common intraoral benign salivary gland neoplasm (60%–80% of all cases), followed by canalicular adenoma, over 80% of which occur in the upper lip mucosa ( Fig. 13.5 ).

FIG. 13.5, (A and B) Pleomorphic adenoma of the palatal mucosa. (C) Canalicular adenoma of the upper lip mucosa. (D) Canalicular adenoma showing circumscription and how it “pops” out at surgery.

Etiopathogenesis and histopathologic features

Over 90% of pleomorphic adenomas are positive for PLAG1 or HMGA2 rearrangements. The fusion partners are listed in Table 13.1 .

  • There is a partially encapsulated or nonencapsulated but discrete tumor with a biphasic pattern exhibiting a proliferation of ducts composed of low cuboidal cells with a surrounding cuff of epithelioid myoepithelial cells, with the myoepithelial cells streaming into the myxochondroid stroma. Pseudopod-like extensions into the capsule are not infrequent. Solid and cribriform patterns are common; rarely, tumors have a reticulated pattern. The cellular variant consists of sheets of myoepithelial cells and ducts with little stroma, although most tumors have abundant stroma ( Figs. 13.6–13.9 ).

    FIG. 13.6, Pleomorphic adenoma. (A) Encapsulated tumor with many ducts and prominent myxochondroid stroma. (B) Ducts surrounded by myoepithelial cells that merge into hyalinized stroma. (C) Ducts with surrounding epithelioid myoepithelial cells that merge into myxoid stroma that contains spindled myoepithelial cells. (D) Myxochondroid areas within the stroma.

    FIG. 13.7, Pleomorphic adenoma. (A) Cystic tumor with myxoid and hyalinized stroma. (B) Ducts are surrounded by sheets of myoepithelial cells, some of which are plasmacytoid while those in the myxoid stroma are spindled. Pleomorphic adenoma with hyaline stroma. (C) Tumor with extensive hyalinization. (D) Ducts exhibit benign cytology surrounded by densely hyalinized stroma.

    FIG. 13.8, (A) Pleomorphic adenoma exhibiting tumor extension into the capsule via a pseudopod. (B) Reticulated pleomorphic adenoma. (C and D) Cellular pleomorphic adenoma with tightly packed cells with little stroma but without significant atypia.

    FIG. 13.9, Myxoid pleomorphic adenoma. (A) Myxoid tumor containing many islands and cords of tumor cells; rare ductal structures are present. (B) Epithelioid and spindled myoepithelial cells in myxoid stroma.

  • Oncocytes, squamous metaplasia, keratin pearls, keratin cysts, clusters of sebaceous cells, and foci of mucous cells may be present. A pure oncocytic variant exists but is not usually seen in the minor glands of the oral cavity ( Fig. 13.10 ).

    FIG. 13.10, Pleomorphic adenoma. (A) Pleomorphic adenoma exhibiting squamous metaplasia and keratin formation. (B) Ducts containing mucous cells and crystalline structures. (C) Crystalline bodies within the stroma in a myxoid pleomorphic adenoma. (D) Lipometaplasia in a spindle cell myoepithelioma.

  • Myoepithelial cells may be epithelioid, spindled, stellate, plasmacytoid, or clear; plasmacytoid myoepithelial cells have abundant eosinophilic cytoplasm and eccentric nuclei that vary in shape and size, dispersed chromatin, and small or inconspicuous nucleoli ( Fig. 13.11 ).

    FIG. 13.11, Pleomorphic adenoma. (A) Sheets of plasmacytoid myoepithelial cells with focal duct formation. (B) Cells with eccentric pleomorphic nuclei and abundant eosinophilic cytoplasm.

  • The stroma which may be myxoid or hyalinized may exhibit osteochondroid material, mature adipocytes, and tyrosine crystals ( Figs. 13.6 and 13.10 ).

  • Myoepithelial cells are positive for S100 protein, vimentin, calponin, smooth muscle actin (SMA), maspin, smooth muscle myosin long chain, GFAP, p63, p40, and SOX10 ( Fig. 13.12 ).

    FIG. 13.12, Pleomorphic adenoma with prominent plasmacytoid myoepithelial cells. (A) All tumor cells positive for S100 protein. (B) Plasmacytoid cells are negative for p40 and for smooth musce actin (C) though the non-plasmacytoid tumor cells are positive. (D) Most tumor cells are positive for K7.

  • Significant cytologic atypia (not just variation in nuclear shape and size) is seen in intracapsular, in situ carcinoma, or noninvasive carcinoma ex pleomorphic adenoma; these are usually strongly associated with the presence of stromal hyalinization, hyaline nodules, and dystrophic calcifications.

Differential diagnosis

  • Apocrine chondroid syringoma of the skin (presenting on the lip) may appear similar, although there may be apocrine decapitation secretion within ducts and follicular and sebaceous differentiation.

  • Spindle cell lipoma or other benign mesenchymal neoplasm with bone, cartilage, and fat differentiation such as osteolipoma do not show immunopositivity for keratin within the spindle cells.

  • Adenoid cystic carcinoma may be considered if the tumor has significant cribriform architecture but there are true ducts and pseudoducts, and cells exhibit hyperchromatic and angular nuclei, that are positive for MYB by immunohistochemistry.

  • The presence of significant hyalinization and calcifications must prompt a search for carcinoma ex pleomorphic adenoma , the two most common of which are salivary duct carcinoma and myoepithelial carcinoma. Hyalinized nodules within salivary duct carcinoma or myoepithelial carcinoma are often associated with PLAG1 and HMGA2 in 80% to 90% of cases, suggesting that these nodules represent senescent areas of pleomorphic adenoma ( Fig. 13.13 ).

    • Intracapsular carcinoma ex pleomorphic adenoma is the term used for a carcinoma or adenocarcinoma that develops within the pleomorphic adenoma that does not invade the capsule while the intracapsular intraductal carcinoma exhibits malignant cells that replace benign ductal cells of the pleomorphic adenoma

    • Minimally invasive carcinoma exhibits less than 6 mm of capsular invasion although this number varies depending on the study.

    • Invasive carcinoma extends beyond 6 mm of the capsule. As expected, invasive carcinoma has a worse outcome than intracapsular and minimally invasive lesions.

    FIG. 13.13, Carcinoma ex pleomorphic adenoma of the upper lip. (A) Pleomorphic adenoma with extensive hyalinization and adenocarcinoma (right) . (B) Remnant pleomorphic adenoma. (C) Area of adenocarcinoma with comedonecrosis. (D) Carcinoma with pleomorphic nuclei.

  • Myoepithelial carcinomas rarely occur intraorally and most are of the epithelioid or clear cell type; tumor cells exhibit significant cytologic atypia.

Management and prognosis

  • Excision with clear margins is the treatment of choice for pleomorphic adenoma, and the recurrence rate is insignificant for intraoral lesions.

  • Malignant transformation occurs in long-standing lesions in less than 5% of cases.

  • Tumors with copy gains of both EGFR and HER2 may have poor prognosis but most of these have been reported within the parotid gland.

References

  • Afshari MK, Fehr A, Nevado PT, Andersson MK, Stenman G. Activation of PLAG1 and HMGA2 by gene fusions involving the transcriptional regulator gene NFIB. Genes Chromosomes Cancer . 2020;59:652-660.

  • Bahrami A, Perez-Ordonez B, Dalton JD, Weinreb I. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions. Histopathology . 2013;63:250-262.

  • Buchner A, Merrell PW, Carpenter WM. Relative frequency of intra-oral minor salivary gland tumors: a study of 380 cases from northern California and comparison to reports from other parts of the world. J Oral Pathol Med . 2007;36:207-214.

  • Haskell HD, Butt KM, Woo SB. Pleomorphic adenoma with extensive lipometaplasia: report of three cases. Am J Surg Pathol . 2005;29:1389-1393.

  • Katabi N, Ghossein R, Ho A, et al. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts. Hum Pathol . 2015;46:26-33.

  • Matsuyama A, Hisaoka M, Nagao Y, Hashimoto H. Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study. Virchows Arch . 2011;458:583-592.

  • Nishijima T, Yamamoto H, Nakano T, et al. Dual gain of HER2 and EGFR gene copy numbers impacts the prognosis of carcinoma ex pleomorphic adenoma. Hum Pathol . 2015;46:1730-1743.

  • Pei J, Liu JC, Ehya H, Wei S. BOC-PLAG1, a new fusion gene of pleomorphic adenoma: identified in a fine-needle aspirate by RNA next-generation sequencing. Diagn Cytopathol . 2021;49:790-792.

  • Rito M, Fonseca I. Carcinoma ex-pleomorphic adenoma of the salivary glands has a high risk of progression when the tumor invades more than 2.5 mm beyond the capsule of the residual pleomorphic adenoma. Virchows Arch . 2016;468:297-303.

  • Rotellini M, Palomba A, Baroni G, Franchi A. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors. Appl Immunohistochem Mol Morphol . 2014;22:390-394.

  • Savera AT, Sloman A, Huvos AG, Klimstra DS. Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 25 patients. Am J Surg Pathol . 2000;24:761-774.

  • Wang C, Zhang Z, Ge Y, et al. Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 29 patients. J Oral Maxillofac Surg . 2015;73:1938-1945.

  • Weiler C, Zengel P, van der Wal JE, et al. Carcinoma ex pleomorphic adenoma with special reference to the prognostic significance of histological progression: a clinicopathological investigation of 41 cases. Histopathology . 2011;59:741-750.

  • Yang S, Li L, Zeng M, et al. Myoepithelial carcinoma of intraoral minor salivary glands: a clinicopathological study of 7 cases and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2010;110:85-193.

Myoepithelioma

In the past, this tumor was considered a monophasic variant of the pleomorphic adenoma with myoepithelial cells exclusively, but because of genomic differences, it is now classified as a separate neoplasm. Those tumors that exhibit occasional ducts should be classified as pleomorphic adenoma, myoepithelial predominant type.

Etiopathogenesis and histopathologic features

A few cases show EWSR1 rearrangements and the oncocytic variant exhibits NTF3::PLAG1 , FBXO32::PLAG1 , and GEM::PLAG1 fusions.

  • This is a well-circumscribed monophasic tumor that consists of a proliferation of myoepithelial cells that may be epithelioid, spindled and stellate, plasmacytoid, clear or a combination of these cell types ( Fig. 13.14 ). The plasmacytoid variant has large, polyhedral cells with abundant eosinophilic cytoplasm and eccentric nuclei that may vary in size and shape but do not show mitotic figures. Tumor cells may be arranged in sheets, cords, and trabeculae and rarely may exhibit a reticulated pattern. Ducts are not present.

    FIG. 13.14, Spindle cell myoepithelioma of palate. (A) Spindle cell proliferation with formation of cartilage and fat. (B) Spindled myoepithelial cells associated with osteochondroid material. (B and C) Myoepithelioma composed of sheets of myoepithelial cells without duct formation. (B) Plasmacytoid myoepithelial cells with abundant eosinophilic cytoplasm and eccentric nuclei. (E and F) Myoepithelioma composed of sheets of epithelioid cells with capsular infiltration.

  • The stroma may be myxoid, myxochondroid, or hyalinized, and bone and cartilage may be present.

  • An oncocytic variant exists where the tumor cells have abundant brightly eosinophilic cytoplasm but is positive for markers for myoepithelial differentiation by immunostaining.

  • Cells are positive for keratin especially K14, S100 protein, SOX10, p63, SMA, and calponin.

Differential diagnosis

  • Pleomorphic adenoma is a biphasic tumor and always contains ducts even if they are few in number.

  • Plasmacytoma has coarse “clock-face” chromatin and a distinct perinuclear zone of Hopf, and tumor cells are CD138+, MUM1+, and negative for S100 protein, p63, and keratin.

  • Interestingly, soft tissue myoepithelioma exhibits PLAG1 rearrangement in approximately 30% of cases and EWSR1 rearrangements in approximately 45% of cases.

  • Myoepithelial carcinoma exhibits significant cytologic atypia and there is a variant termed secretory myoepithelial carcinoma that contains strands, cords, and sheets of vacuolated signet ring cells positive for K7 and mucin, and variably positive for p63, S100 protein, calponin, and SMA. These had been previously classified as signet ring adenocarcinoma or even mucinous myoepithelioma and these likely represent mucinous adenocarcinoma (see later).

References

  • Antonescu CR, Zhang L, Shao SY, et al. Frequent PLAG1 gene rearrangements in skin and soft tissue myoepithelioma with ductal differentiation. Genes Chromosomes Cancer . 2013;52:675-682.

  • Bastaki J, Summersgill K. Signet-ring cell (mucin-producing) adenocarcinoma of minor salivary glands: report of a case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2010;110:e33-36.

  • Bastaki JM, Purgina BM, Dacic S, Seethala RR. Secretory myoepithelial carcinoma: a histologic and molecular survey and a proposed nomenclature for mucin producing signet ring tumors. Head Neck Pathol . 2014;8:250-260.

  • Foschini MP, Baldovini C, Pennesi MG, Cocchi R, Simpson RH. Signet ring cell tumor of the minor salivary gland exhibiting benign behavior. Hum Pathol . 2012;43:303-306.

  • Ghannoum JE, Freedman PD. Signet-ring cell (mucin-producing) adenocarcinomas of minor salivary glands. Am J Surg Pathol . 2004; 28:89-93.

  • Gnepp DR. Mucinous myoepithelioma, a recently described new myoepithelioma variant. Head Neck Pathol . 2013;7(suppl 1):S85-S89.

  • Jo VY, Fletcher CD. Myoepithelial neoplasms of soft tissue: an updated review of the clinicopathologic, immunophenotypic, and genetic features. Head Neck Pathol . 2015;9:32-38.

  • Ni H, Zhao PY, Wang XT, et al. EWSR1 rearrangement is present in a subset of myoepithelial tumors of salivary glands with variable morphology and does not correlate with clinical behavior. Ann Diagn Pathol . 2017;28:19-23.

  • Sciubba JJ. Myoepithelioma of salivary glands: report of 23 cases. Cancer . 1982;47:562-572.

Canalicular adenoma

Clinical findings

  • This occurs most frequently in the seventh decade with a 2:1 female predilection; 80% occur as a mobile, firm nodule in the upper lip mucosa with approximately 10% occurring in the buccal mucosa; multifocal tumors occur infrequently.

Etiopathogenesis and histopathologic features

Genomic changes have yet to be identifed.

  • This is a monophasic tumor composed of an encapsulated proliferation of cuboidal-to-columnar cells, usually in two layers, in interconnected trabeculae and ribbon-like strands forming narrow, elongated ducts and channels (canaliculi); where two strands meet, knots or beads of cells form. Some tumors have thicker bands of cells resulting in a trabecular pattern. Cells have slightly palisaded, pseudostratified, ovoid nuclei with dispersed chromatin and small nucleoli; occasional mitotic figures, oncocytes, and mucous cells may be seen and there may be luminal epithelial spherules or morules. Cystic change may be associated with papillary epithelial protrusions. ( Figs. 13.15 and 13.16 ).

    FIG. 13.15, Canalicular adenoma. (A) Encapsulated tumor with abundant hemorrhage and interconnected strands of cells. (B) Delicate ribbons of cells in myxochondroid stroma. (C) Single- and double-layered basaloid cells forming ductal structures and epithelial knots and beads, and collagen-poor mucinous stroma with ectatic vessels. Canalicular adenoma with tubular morphology. (D) Irregular strands and tubular structures in myxochondroid stroma. (E) Strands and islands of tumor cells, some with central lumens, delicate vessels, and collagen-poor stroma. (F) Strands are double layered or multilayered with epithelial knots or beads where tumor strands intersect.

    FIG. 13.16, Canalicular adenoma. (A) Tumor with cystic spaces and both myxoid and hyalinized stroma. (B) Interconnected strands of basaloid cells with a trabecular pattern in myxoid stroma and beads or knots of cells where two strands intersect. (C) Tumor cells are positive for vimentin. (D) Tumor cells are positive for S100 protein.

  • The stroma is collagen-poor and mucinous/myxoid with prominent ectatic capillaries; other findings include hemorrhage and psammomatoid spherical calcifications.

  • Cells are positive for AE1/3, K7, K19, EMA, S100 protein, vimentin, CD117, and SOX10, and negative for SMA ( Fig. 13.16 C–D); the epithelial spherules are positive for p16 and p63, and GFAP is present in tumor cells at the tumor-capsule interface.

  • Foci of early canalicular adenoma within adjacent gland lobules is not unusual ( Fig. 13.17 ).

    FIG. 13.17, Canalicular adenoma. (A) Cystic tumor with a trabecular pattern, and incipient tumor in the adjacent salivary gland (arrow) . (B) In another lobule, incipient canalicular adenoma is also present.

Differential diagnosis

  • Trabecular basal cell adenoma is a biphasic tumor that is rare in the minor glands and exhibits hyalinized stroma, and contains both ductal and myoepithelial cell populations with positivity for myoepithelial markers such as p63 in the abluminal cells, as well as nuclear positivity for β-catenin and LEF-1.

  • Eccrine spiradenoma, a skin adnexal tumor that may occur on the lip forms lobules and broad trabeculae of tumor cells with two cell populations, and hyalinized material and lymphocytes are present.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here